Cullinan Oncology, Inc. (CGEM)
NGS · Common · CUSIP 230031106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CGEM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
230031106
Market Cap
Small Cap
IPO
1/8/2021 · $21.00/share
Previous Name
Cullinan Management, Inc.
Business: Cullinan Oncology, Inc. is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Company Contact

CEO
Owen Hughes
CFO
Jeff Trigilio
Headquarters
One Main Street, Suite 520, Cambridge, MA 02142
Phone
617-410-4650
Investor Relations
Chad Messer · 203-464-8900 · cmesser@cullinanoncology.com
General Email
investors@cullinanoncology.com
SEC EDGAR Filings
View filings »